核子医学影像设备市场：规模、占有率、法规、报销、安装单位以及 2036 年各细分市场预测

核子医学设备使用放射性物质（也称为核子医学或放射性药物），透过口服或静脉注射到体内。这些系统捕捉放射性药物发射的辐射并创建身体内部结构和活动的图像。这些影像使医生能够看到人体内部，找出疾病或损伤的原因，并做出准确的诊断。

核子医学影像是一种非侵入性医疗技术，使用放射性追踪剂（例如F-18氟脱氧葡萄糖）来评估和诊断各种身体功能和疾病，包括癌症、心臟、胃肠道、内分泌和神经系统疾病。核子医学影像设备分为正子断层扫瞄 (PET) 系统和单光子发射电脑断层扫瞄 (SPECT) 系统。这些系统的进阶版包括 PET/CT、PET/MRI、SPECT/CT 和 SPECT/MRI，结合了 PET 和 CT/MRI 或 SPECT 和 CT/MRI 功能。

本报告对全球核子医学影像设备市场进行了详细分析，包括竞争格局、SWOT 分析、2015 年至 2036 年各细分市场的年度总销售额和市场预测、以及各地区和国家的趋势。

目录

目前核医学影像设备的市场现况及竞争格局

• 洞察关键产业趋势
• 2015 年至 2036 年核医影像设备各细分市场总收入及市场预测
• 有关单位、平均售价和市场价值的详细数据

全球、区域和国家见解

• 核子医学影像设备市场的 SWOT 分析
• 深入瞭解核医影像设备市场的竞争动态与趋势
• 按国家/地区划分的医疗保健系统概览
• 各国报销政策
• 各国医疗技术法规现状

Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.

Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.

Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers, such as F-18 Fluorodeoxyglucose, to evaluate and diagnose various bodily functions and diseases, including cancers, cardiac, gastrointestinal, endocrine, and neurological conditions. Nuclear Imaging Equipment's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI, incorporating features from both PET and CT/MRI or SPECT and CT/MRI.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Nuclear Imaging Equipment and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Nuclear Imaging Equipment market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Nuclear Imaging Equipment market.
• Competitive dynamics insights and trends provided for Nuclear Imaging Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: GE HealthCare Technologies Inc, Siemens Healthineers AG, Shanghai United Imaging Healthcare Co Ltd, Canon Medical Systems Corp and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Nuclear Imaging Equipment marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Nuclear Imaging Equipment market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Nuclear Imaging Equipment market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Nuclear Imaging Equipment market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.